LOXO-101
-
LOXO-101
structure -
-
CAS No:
1223405-08-0
-
Formula:
C21H24F2N6O6S
-
Chemical Name:
LOXO-101
-
Synonyms:
Larotrectinib sulfate;LOXO-101 sulfate;ARRY-470 sulfate;UNII-RDF76R62ID;RDF76R62ID;(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide sulfate;(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide sulfate;Vitrakvi (TN);1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, sulfate (1:1);1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1)
- Categories:
-
CAS No:
Description
Larotrectinib (LOXO-101) sulfate is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
Larotrectinib Sulfate is the sulfate salt form of larotrectinib, an orally available, tropomyosin receptor kinase (Trk) inhibitor, with potential antineoplastic activity. Upon administration, larotrectinib binds to Trk, thereby preventing neurotrophin-Trk interaction and Trk activation, which results in both the induction of cellular apoptosis and the inhibition of cell growth in tumors that overexpress Trk. Trk, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth and survival.
Drug Information
Vitrakvi as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have no satisfactory treatment options.
LOXO-101 Use and Manufacturing
Human drugs -> Vitrakvi -> EMA Drug Category|Antineoplastic agents -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:526.5
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:3
Exact Mass:526.14461000
Monoisotopic Mass:526.14461000
Topological Polar Surface Area:169
Heavy Atom Count:36
Complexity:741
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of LOXO-101
-
CN
2 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVEInquiryCAS No.: 1223405-08-0Grade: Analytical ReagentContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
9 YRS
Business licensed Certified factoryManufactory Supplier of Imatinib mesylate -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 1223405-08-0Grade: Industrial GradeContent: 99% -
CN
1 YR
Business licensedTrader Supplier of Peptides,API,IntermediateInquiryCAS No.: 1223405-08-0Grade: medical gradeContent: 98%
Learn More Other Chemicals
-
2-Aminotetralin
2954-50-9
-
6-Carboxyfluorescein succinimidyl ester
92557-81-8
-
2-diphenylphosphanylphenol
60254-10-6
-
(-)-2-Azabicyclo[2.2.1]hept-5-en-3-one Formula
79200-56-9
-
(1R)-2,2-Dimethylcyclopropanecarboxamide Formula
106462-18-4
-
Pyrrolidine, 3-fluoro-, hydrochloride (1:1), (3R)- Formula
136725-55-8
-
Benzeneacetyl chloride, α-amino-, hydrochloride (1:1), (αR)- Structure
39878-87-0
-
(+)-3-(Trifluoroacetyl)camphor Structure
51800-98-7
-
What is N-[2-(Diethylamino)ethyl]-2-propenamide
10595-45-6
-
What is (5R)-2,2,3-TRIMETHYL-5-PHENYLMETHYL-4-IMIDAZOLIDINONEMONOHYDROCHLORIDE
323196-43-6